RESUMEN
Hematopoietic stem cells (HSCs, CD34+ cells) have shown therapeutic efficacy for transplantation in various hematological disorders. However, a large quantity of HSCs is required for transplantation. Therefore, strategies to increase HSC numbers and preserve HSC functions through ex vivo culture are critically required. Here, we report that expansion medium supplemented with ASPP 049, a diarylheptanoid isolated from Curcuma comosa, and a cocktail of cytokines markedly increased numbers of adult CD34+ cells. Interestingly, phenotypically defined primitive HSCs (CD34+CD38-CD90+) were significantly increased under ASPP 049 treatment relative to control. ASPP 049 treatment also improved two functional properties of HSCs, as evidenced by an increased number of CD34+CD38- cells in secondary culture (self-renewal) and the growth of colony-forming units as assessed by colony formation assay (multilineage differentiation). Transplantation of cultured CD34+ cells into immunodeficient mice demonstrated the long-term reconstitution and differentiation ability of ASPP 049-expanded cells. RNA sequencing and KEGG analysis revealed that Hippo signaling was the most likely pathway involved in the effects of ASPP 049. These results suggest that ASPP 049 improved ex vivo expansion and functional preservation of expanded HSCs. Our findings provide a rationale for the use of ASPP 049 to grow HSCs prior to hematological disease treatment.
Asunto(s)
Células Madre Adultas/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Autorrenovación de las Células/efectos de los fármacos , Diarilheptanoides/farmacología , Células Madre Hematopoyéticas/efectos de los fármacos , Células Madre Adultas/fisiología , Células Madre Adultas/trasplante , Animales , Antígenos CD34/metabolismo , Diferenciación Celular , Linaje de la Célula , Células Cultivadas , Curcuma/química , Diarilheptanoides/aislamiento & purificación , Trasplante de Células Madre Hematopoyéticas , Humanos , Ratones Desnudos , Fenotipo , Factores de TiempoRESUMEN
Adult neural stem and progenitor cells (NSPCs) contribute to learning, memory, maintenance of homeostasis, energy metabolism and many other essential processes. They are highly heterogeneous populations that require input from a regionally distinct microenvironment including a mix of neurons, oligodendrocytes, astrocytes, ependymal cells, NG2+ glia, vasculature, cerebrospinal fluid (CSF), and others. The diversity of NSPCs is present in all three major parts of the CNS, i.e., the brain, spinal cord, and retina. Intrinsic and extrinsic signals, e.g., neurotrophic and growth factors, master transcription factors, and mechanical properties of the extracellular matrix (ECM), collectively regulate activities and characteristics of NSPCs: quiescence/survival, proliferation, migration, differentiation, and integration. This review discusses the heterogeneous NSPC populations in the normal physiology and highlights their potentials and roles in injured/diseased states for regenerative medicine.
Asunto(s)
Células Madre Adultas/fisiología , Células-Madre Neurales/fisiología , Enfermedades Neurodegenerativas/patología , Traumatismos de la Médula Espinal/patología , Células Madre Adultas/citología , Células Madre Adultas/trasplante , Animales , Antígenos/metabolismo , Diferenciación Celular , Epéndimo/citología , Epéndimo/fisiología , Humanos , Células-Madre Neurales/citología , Células-Madre Neurales/trasplante , Enfermedades Neurodegenerativas/terapia , Proteoglicanos/metabolismo , Medicina Regenerativa , Traumatismos de la Médula Espinal/terapiaRESUMEN
(1) Background: We established a new bladder ischemia rat model through bilateral partial iliac arterial occlusion (BPAO) and investigated the therapeutic effect of adipose-derived stem cells (ADSCs) and ADSC-derived microvesicles (MVs); (2) Methods: The study included four groups: (1) sham, (2) BPAO, (3) BPAO + ADSCs, and (4) BPAO + ADSC-derived MVs. Female Wistar rats with BPAO were injected with ADSCs or ADSC-derived MVs through the femoral artery. Doppler flowmetry and real-time laser speckle contrast imaging were performed to quantify blood flow in the common iliac arteries and bladder microcirculation. A 24-h behavior study and transcystometrogram were conducted after 2 weeks. Bladder histology, immunostaining, and lipid peroxidation assay were performed. The expressions of P2X2, P2X3, M2, and M3 receptors and nerve growth factor (NGF) were evaluated; (3) Results: BPAO significantly reduced bladder microcirculation, intercontraction interval (ICI), and bladder volume and increased the amplitude of nonvoiding contraction, neutrophil infiltration, and malondialdehyde and NGF levels. ADSCs and ADSC-derived MVs significantly ameliorated these effects. The results of Western blot showed that the BPAO group exhibited the highest expression of M3 and P2X2 receptors. ADSCs significantly attenuated the expressions of M2 and P2X2 receptors. ADSC-derived MVs significantly attenuated the expressions of M3 and P2X2 receptors; (4) Conclusions: ADSCs and ADSC-derived MVs ameliorated the adverse effects of BPAO including bladder overactivity, bladder ischemia, and oxidative stress. Inflammation, muscarinic signaling, purinergic signaling, and NGF might be involved in the therapeutic mechanism.
Asunto(s)
Tejido Adiposo/citología , Células Madre Adultas/trasplante , Micropartículas Derivadas de Células/trasplante , Vejiga Urinaria Hiperactiva/terapia , Células Madre Adultas/citología , Animales , Arteriopatías Oclusivas/complicaciones , Arteriopatías Oclusivas/terapia , Micropartículas Derivadas de Células/fisiología , Modelos Animales de Enfermedad , Femenino , Arteria Ilíaca/patología , Isquemia/etiología , Isquemia/terapia , Ratas , Ratas Wistar , Vejiga Urinaria/patología , Vejiga Urinaria Hiperactiva/etiologíaRESUMEN
The prevalence of peripheral arterial disease (PAD) in the United States exceeds 10 million people, and PAD is a significant cause of morbidity and mortality across the globe. PAD is typically caused by atherosclerotic obstructions in the large arteries to the leg(s). The most common clinical consequences of PAD include pain on walking (claudication), impaired functional capacity, pain at rest, and loss of tissue integrity in the distal limbs that may lead to lower extremity amputation. Patients with PAD also have higher than expected rates of myocardial infarction, stroke, and cardiovascular death. Despite advances in surgical and endovascular procedures, revascularization procedures may be suboptimal in relieving symptoms, and some patients with PAD cannot be treated because of comorbid conditions. In some cases, relieving obstructive disease in the large conduit arteries does not assure complete limb salvage because of severe microvascular disease. Despite several decades of investigational efforts, medical therapies to improve perfusion to the distal limb are of limited benefit. Whereas recent studies of anticoagulant (eg, rivaroxaban) and intensive lipid lowering (such as PCSK9 [proprotein convertase subtilisin/kexin type 9] inhibitors) have reduced major cardiovascular and limb events in PAD populations, chronic ischemia of the limb remains largely resistant to medical therapy. Experimental approaches to improve limb outcomes have included the administration of angiogenic cytokines (either as recombinant protein or as gene therapy) as well as cell therapy. Although early angiogenesis and cell therapy studies were promising, these studies lacked sufficient control groups and larger randomized clinical trials have yet to achieve significant benefit. This review will focus on what has been learned to advance medical revascularization for PAD and how that information might lead to novel approaches for therapeutic angiogenesis and arteriogenesis for PAD.
Asunto(s)
Inductores de la Angiogénesis/uso terapéutico , Enfermedad Arterial Periférica/terapia , Células Madre Adultas/trasplante , Amputación Quirúrgica , Moduladores de la Angiogénesis/uso terapéutico , Animales , Anticoagulantes/uso terapéutico , Aterosclerosis/complicaciones , Endotelio Vascular/metabolismo , Procedimientos Endovasculares , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Claudicación Intermitente/etiología , Recuperación del Miembro , Extremidad Inferior/irrigación sanguínea , Extremidad Inferior/cirugía , Ratones , Microcirculación , Infarto del Miocardio/epidemiología , Neovascularización Fisiológica/fisiología , Enfermedad Arterial Periférica/epidemiología , Prevalencia , Proproteína Convertasa 9 , ARN no Traducido/uso terapéutico , Accidente Cerebrovascular/epidemiologíaRESUMEN
Endometrial damage is an important cause of female reproductive problems, manifested as menstrual abnormalities, infertility, recurrent pregnancy loss, and other complications. These conditions are collectively termed "Asherman syndrome" (AS) and are typically associated with recurrent induced pregnancy terminations, repeated diagnostic curettage and intrauterine infections. Cancer treatment also has unexpected detrimental side effects on endometrial function in survivors independently of ovarian effects. Endometrial stem cells act in the regeneration of the endometrium and in repair through direct differentiation or paracrine effects. Nonendometrial adult stem cells, such as bone marrow-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells, with autologous and allogenic applications, can also repair injured endometrial tissue in animal models of AS and in human studies. However, there remains a lack of research on the repair of the damaged endometrium after the reversal of tumors, especially endometrial cancers. Here, we review the biological mechanisms of endometrial regeneration, and research progress and challenges for adult stem cell therapy for damaged endometrium, and discuss the potential applications of their use for endometrial repair after cancer remission, especially in endometrial cancers. Successful application of such cells will improve reproductive parameters in patients with AS or cancer. Significance: The endometrium is the fertile ground for embryos, but damage to the endometrium will greatly impair female fertility. Adult stem cells combined with tissue engineering scaffold materials or not have made great progress in repairing the injured endometrium due to benign lesions. However, due to the lack of research on the repair of the damaged endometrium caused by malignant tumors or tumor therapies, the safety and effectiveness of such stem cell-based therapies need to be further explored. This review focuses on the molecular insights and clinical application potential of adult stem cells in endometrial regeneration and discusses the possible challenges or difficulties that need to be overcome in stem cell-based therapies for tumor survivors. The development of adult stem cell-related new programs will help repair damaged endometrium safely and effectively and meet fertility needs in tumor survivors.
Asunto(s)
Células Madre Adultas/fisiología , Endometrio/fisiología , Ginatresia/fisiopatología , Regeneración/fisiología , Aborto Habitual/etiología , Aborto Habitual/prevención & control , Células Madre Adultas/trasplante , Amnios/citología , Animales , Antígenos de Diferenciación/análisis , Células de la Médula Ósea , Senescencia Celular , Modelos Animales de Enfermedad , Neoplasias Endometriales/fisiopatología , Neoplasias Endometriales/terapia , Endometrio/irrigación sanguínea , Endometrio/citología , Endometrio/lesiones , Femenino , Sangre Fetal/citología , Ginatresia/complicaciones , Ginatresia/terapia , Humanos , Hidrogeles , Células Madre Pluripotentes Inducidas/trasplante , Infertilidad Femenina/etiología , Infertilidad Femenina/terapia , Menstruación , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Mucosa Bucal/citología , Células de Población Lateral/citología , Nicho de Células Madre , Ingeniería de Tejidos/métodos , Andamios del TejidoRESUMEN
Articular chondral lesions, caused either by trauma or chronic cartilage diseases such as osteoarthritis, present very low ability to self-regenerate. Thus, their current management is basically symptomatic, progressing very often to invasive procedures or even arthroplasties. The use of amniotic fluid stem cells (AFSCs), due to their multipotentiality and plasticity, associated with scaffolds, is a promising alternative for the reconstruction of articular cartilage. Therefore, this study aimed to investigate the chondrogenic potential of AFSCs in a micromass system (high-density cell culture) under insulin-like growth factor 1 (IGF-1) stimuli, as well as to look at their potential to differentiate directly when cultured in a porous chitosan-xanthan (CX) scaffold. The experiments were performed with a CD117 positive cell population, with expression of markers (CD117, SSEA-4, Oct-4 and NANOG), selected from AFSCs, after immunomagnetic separation. The cells were cultured in both a micromass system and directly in the scaffold, in the presence of IGF-1. Differentiation to chondrocytes was confirmed by histology and by using immunohistochemistry. The construct cell-scaffold was also analyzed by scanning electron microscopy (SEM). The results demonstrated the chondrogenic potential of AFSCs cultivated directly in CX scaffolds and also in the micromass system. Such findings support and stimulate future studies using these constructs in osteoarthritic animal models.
Asunto(s)
Células Madre Adultas/citología , Cartílago Articular/efectos de los fármacos , Condrogénesis/genética , Osteoartritis/genética , Andamios del Tejido/química , Células Madre Adultas/trasplante , Líquido Amniótico/citología , Cartílago Articular/crecimiento & desarrollo , Cartílago Articular/ultraestructura , Técnicas de Cultivo de Célula , Diferenciación Celular/efectos de los fármacos , Quitosano/farmacología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Humanos , Factor I del Crecimiento Similar a la Insulina/farmacología , Microscopía Electrónica de Rastreo , Osteoartritis/patología , Osteoartritis/terapia , Polisacáridos Bacterianos/farmacología , Proteínas Proto-Oncogénicas c-kit/genética , Ingeniería de Tejidos/métodosRESUMEN
Upper limb lymphedema is one of the most common complications after breast cancer surgery and radiotherapy. Despite various physical therapy and surgical options available, the impaired lymph fluid drainage may be progressive due to lymphatic vascular insufficiency making treatment more difficulty. Stem cell therapy provides a promising alternative in the treatment of various chronic diseases. The wide applicability of cell therapy has been reviewed throughout literature. This review provides an overview of recent progress in the therapeutic effect of adult stem cells for primary and secondary lymphedema after breast surgery in preclinical studies and clinical cases. We start with a brief introduction about the pathophysiological mechanisms of postmastectomy lymphedema. Regarding existing treatments, we systematically summarize the benefits and limitations of recent progress. Because of their multidirectional differentiation potential and growth factor secretion, stem cell therapy shows promising results in the management of light to severe lymphedema. Increasing evidences have demonstrated a noticeable reduction in postmastectomy lymphedema and increased lymph-angiogenesis after specific stem cell therapy. Current data suggests that stem cell therapy in lymphedema treatment provides reversal of pathological reorganization associated with lymphedema progression. Finally, we propose potential strategies for overcoming the challenges in the development of multipotent progenitor cells for the treatment and prevention of lymphedema in clinical practice.
Asunto(s)
Células Madre Adultas/trasplante , Linfedema del Cáncer de Mama/terapia , Neoplasias de la Mama/cirugía , Mastectomía/efectos adversos , Trasplante de Células Madre Mesenquimatosas/métodos , Animales , Linfedema del Cáncer de Mama/diagnóstico , Linfedema del Cáncer de Mama/etiología , Terapia Combinada/métodos , Modelos Animales de Enfermedad , Femenino , Humanos , Índice de Severidad de la Enfermedad , Resultado del TratamientoRESUMEN
Involvement of the cerebellum in the pathophysiology of hypoxic-ischemic encephalopathy (HIE) in preterm infants is increasingly recognized. We aimed to assess the neuroprotective potential of intravenously administered multipotent adult progenitor cells (MAPCs) in the preterm cerebellum. Instrumented preterm ovine fetuses were subjected to transient global hypoxia-ischemia (HI) by 25 minutes of umbilical cord occlusion at 0.7 of gestation. After reperfusion, two doses of MAPCs were administered intravenously. MAPCs are a plastic adherent bone-marrow-derived population of adult progenitor cells with neuroprotective potency in experimental and clinical studies. Global HI caused marked cortical injury in the cerebellum, histologically indicated by disruption of cortical strata, impeded Purkinje cell development, and decreased dendritic arborization. Furthermore, global HI induced histopathological microgliosis, hypomyelination, and disruption of white matter organization. MAPC treatment significantly prevented cortical injury and region-specifically attenuated white matter injury in the cerebellum following global HI. Diffusion tensor imaging (DTI) detected HI-induced injury and MAPC neuroprotection in the preterm cerebellum. This study has demonstrated in a preclinical large animal model that early systemic MAPC therapy improved structural injury of the preterm cerebellum following global HI. Microstructural improvement was detectable with DTI. These findings support the potential of MAPC therapy for the treatment of HIE and the added clinical value of DTI for the detection of cerebellar injury and the evaluation of cell-based therapy.
Asunto(s)
Células Madre Adultas/trasplante , Asfixia , Cerebelo , Hipoxia-Isquemia Encefálica , Células Madre Multipotentes , Animales , Asfixia/terapia , Imagen de Difusión Tensora , Modelos Animales de Enfermedad , Feto , Humanos , Recién Nacido , Recien Nacido Prematuro , Células Madre Multipotentes/trasplante , OvinosRESUMEN
Therapeutic modulation of fate and behavior of somatic stem cells can generate safe and functional cells ex vivo for cell-based therapy, or to repair and regenerate damaged tissues in vivo. Chemical approaches involving small molecules have provided promising approaches for modulating cellular fate and function. These strategies offer opportunities that support regenerative medicine. Here, we discuss strategies targeting somatic stem cells through chemical approaches, highlighting their progression as well as future prospects.
Asunto(s)
Células Madre Adultas/metabolismo , Medicina Regenerativa , Células Madre Adultas/citología , Células Madre Adultas/efectos de los fármacos , Células Madre Adultas/trasplante , Animales , Tratamiento Basado en Trasplante de Células y Tejidos , Humanos , Enfermedades Neurodegenerativas/patología , Enfermedades Neurodegenerativas/terapia , Transducción de Señal/efectos de los fármacos , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacologíaRESUMEN
Inherited photoreceptor degenerations are not treatable diseases and a frequent cause of blindness in working ages. In this study we investigate the safety, integration and possible rescue effects of intravitreal and subretinal transplantation of adult human bone-marrow-derived mononuclear stem cells (hBM-MSCs) in two animal models of inherited photoreceptor degeneration, the P23H-1 and the Royal College of Surgeons (RCS) rat. Immunosuppression was started one day before the injection and continued through the study. The hBM-MSCs were injected in the left eyes and the animals were processed 7, 15, 30 or 60 days later. The retinas were cross-sectioned, and L- and S- cones, microglia, astrocytes and Müller cells were immunodetected. Transplantations had no local adverse effects and the CD45+ cells remained for up to 15 days forming clusters in the vitreous and/or a 2-3-cells-thick layer in the subretinal space after intravitreal or subretinal injections, respectively. We did not observe increased photoreceptor survival nor decreased microglial cell numbers in the injected left eyes. However, the injected eyes showed decreased GFAP immunoreactivity. We conclude that intravitreal or subretinal injection of hBM-MSCs in dystrophic P23H-1 and RCS rats causes a decrease in retinal gliosis but does not have photoreceptor neuroprotective effects, at least in the short term. However, this treatment may have a potential therapeutic effect that merits further investigation.
Asunto(s)
Gliosis/cirugía , Trasplante de Células Madre Mesenquimatosas , Retina/cirugía , Células Fotorreceptoras Retinianas Conos/trasplante , Degeneración Retiniana/cirugía , Células Madre Adultas/trasplante , Animales , Células de la Médula Ósea/citología , Trasplante de Médula Ósea , Supervivencia Celular/fisiología , Modelos Animales de Enfermedad , Gliosis/patología , Humanos , Ratas , Retina/patología , Células Fotorreceptoras Retinianas Conos/patología , Degeneración Retiniana/patologíaRESUMEN
Multiple sclerosis (MS) is an inflammatory demyelination disease in the central nervous system (CNS) characterized by incomplete endogenous remyelination in the chronic phase. A shift of the balance between pro and anti-inflammatory cytokines is one of the important markers in the pathogenesis of MS. This study aimed to evaluate the effects of human adipose derived stem cells (hADSCs) overexpressing interleukin 11 and interleukin 13 (IL-11, 13-hADSCs) on the experimental autoimmune encephalomyelitis (EAE), an animal model of MS.12 days after immunization of C57Bl/6 female mice with MOG35-55 and initial clinical symptoms appearance, the IL-11, 13-hADSCs were injected via the tail vein into the EAE mice. Then, the mice were sacrificed at 30 days post-immunization (DPI) and the spinal cords of experimental groups were extracted for histopathological and real-time RT-PCR studies.The results indicated that the clinical scores and mononuclear cells infiltration into the spinal cords of EAE mice were significantly reduced in mice treated with IL-11, 13-hADSCs. Likewise, the remyelination and oligodendrogenesis were significantly enhanced in the mentioned treatment group. Real-time results demonstrated that pro/anti-inflammatory cytokine genes expression was reversed in IL-11, 13-hADSCs treatment group in comparison to the untreated EAE group.Expression of IL-11 as a neurotrophic cytokine and IL-13 as an anti-inflammatory cytokine by hADSCs could increase the immunomodulatory and neuroprotective effects of hADSCs and be a powerful candidate in stem cell therapy for future treatment of MS.
Asunto(s)
Tejido Adiposo/patología , Células Madre Adultas/fisiología , Encefalomielitis Autoinmune Experimental/terapia , Interleucina-11/metabolismo , Interleucina-13/metabolismo , Esclerosis Múltiple/terapia , Trasplante de Células Madre , Adulto , Células Madre Adultas/trasplante , Animales , Modelos Animales de Enfermedad , Femenino , Humanos , Inmunomodulación , Interleucina-11/genética , Interleucina-13/genética , Ratones , Ratones Endogámicos C57BL , Glicoproteína Mielina-Oligodendrócito/inmunología , Fármacos Neuroprotectores , Fragmentos de Péptidos/inmunología , Adulto JovenRESUMEN
INTRODUCTION: Skeletal muscle-derived stem cells (Sk-MDSCs) are considered promising sources of adult stem cell therapy. Skeletal muscle comprises approximately 40-50% of the total body mass with marked potential for postnatal adaptive response, such as muscle hypertrophy, hyperplasia, atrophy, and regenerative capacity. This strongly suggests that skeletal muscle contains various stem/progenitor cells related to muscle-nerve-vascular tissues, which would support the above postnatal events even in adulthood. AREA COVERED: The focus of this review is the therapeutic potential of the Sk-MDSCs as an adult stem cell autograft. For this purpose, the validity of cell isolation and purification, tissue reconstitution capacity in vivo after transplantation, comparison of the results of basic mouse and preclinical human studies, potential problematic and beneficial aspects, and effective usage have been discussed following the history of clinical applications. EXPERT OPINION: Although the clinical application of Sk-MDSCs began as a therapy for the systemic disease of Duchenne muscular dystrophy, here, through the unique local injection method, therapy for severely damaged peripheral nerves, particularly the long-gap nerve transection, has been introduced. The beneficial aspects of the use of Sk-MDSCs as the source of local tissue transplantation therapy have also been discussed.
Asunto(s)
Células Madre Adultas/trasplante , Músculo Esquelético/citología , Trasplante de Células Madre/métodos , Adulto , Células Madre Adultas/fisiología , Animales , Diferenciación Celular/fisiología , Humanos , Ratones , Distrofia Muscular de Duchenne/terapia , Mioblastos/citología , Mioblastos/fisiología , Traumatismos de los Nervios Periféricos/patología , Traumatismos de los Nervios Periféricos/terapia , Nervios Periféricos/patología , Trasplante de Células Madre/tendencias , Investigación Biomédica Traslacional/métodos , Investigación Biomédica Traslacional/tendenciasAsunto(s)
COVID-19/terapia , Síndrome de Dificultad Respiratoria/terapia , Síndrome de Dificultad Respiratoria/virología , Células Madre Adultas/trasplante , Enzima Convertidora de Angiotensina 2/uso terapéutico , Azitromicina/uso terapéutico , Transfusión de Componentes Sanguíneos , COVID-19/complicaciones , Oxigenación por Membrana Extracorpórea/métodos , Humanos , Hidroxicloroquina/uso terapéutico , Ivermectina/uso terapéutico , Plasma , Proteínas Recombinantes/uso terapéutico , SARS-CoV-2RESUMEN
The development of new therapies for psychiatric disorders is of utmost importance, given the enormous toll these disorders pose to society nowadays. This should be based on the identification of neural substrates and mechanisms that underlie disease etiopathophysiology. Adult neural stem cells (NSCs) have been emerging as a promising platform to counteract brain damage. In this perspective article, we put forth a detailed view of how NSCs operate in the adult brain and influence brain homeostasis, having profound implications at both behavioral and functional levels. We appraise evidence suggesting that adult NSCs play important roles in regulating several forms of brain plasticity, particularly emotional and cognitive flexibility, and that NSC dynamics are altered upon brain pathology. Furthermore, we discuss the potential therapeutic value of utilizing adult endogenous NSCs as vessels for regeneration, highlighting their importance as targets for the treatment of multiple mental illnesses, such as affective disorders, schizophrenia, and addiction. Finally, we speculate on strategies to surpass current challenges in neuropsychiatric disease modeling and brain repair.
Asunto(s)
Células Madre Adultas/trasplante , Trastornos Mentales/terapia , Células-Madre Neurales/trasplante , Animales , Encéfalo/patología , Humanos , Nicho de Células MadreRESUMEN
Adult stem cells have been developed as therapeutics for tissue regeneration and immune regulation due to their self-renewing, differentiating, and paracrine functions. Recently, a variety of adult stem cells from the oral cavity have been discovered, and these dental stem cells mostly exhibit the characteristics of mesenchymal stem cells (MSCs). Dental MSCs can be applied for the replacement of dental and oral tissues against various tissue-damaging conditions including dental caries, periodontitis, and oral cancers, as well as for systemic regulation of excessive inflammation in immune disorders, such as autoimmune diseases and hypersensitivity. Therefore, in this review, we summarized and updated the types of dental stem cells and their functions to exert therapeutic efficacy against diseases.
Asunto(s)
Células Madre Adultas/citología , Enfermedades de la Boca/terapia , Boca/citología , Células Madre Adultas/trasplante , Caries Dental , Humanos , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citologíaRESUMEN
Simple limbal epithelial transplantation (SLET) and cultivated limbal epithelial transplantation (CLET) are proven techniques for treating limbal stem cell deficiency (LSCD). However, the precise regions that are most suitable for preparing explants for transplantation have not been identified conclusively. Accordingly, this in vitro study aimed at determining ideal sites to be selected for tissue harvest for limbal stem cell culture and transplantation. We evaluated cell outgrowth potential and the expression of stem cell markers in cultures from 48 limbal explants from five cadaveric donors. The limbal explants were generated from the three specific sites: Lcor (located innermost and adjacent to the cornea), Lm (middle limbus), and Lconj (located outermost adjacent to the conjunctiva). We found that explants from the Lconj and Lm sites exhibited higher growth potential than those from the Lcor site. Transcript encoding the stem cell marker and p63 isoform, ΔNp63, was detected in cells from Lm and Lconj explants; expression levels were slightly, though significantly (p-value < 0.05), higher in Lm than in Lconj, although expression of ΔNp63α protein was similar in cells from all explants. Differential expression of ATP-Binding Cassette Subfamily G Member 2 (ABCG2) did not reach statistical significance. Immunohistochemistry by indirect immunofluorescence analysis of limbus tissue revealed that the basal layer in explant tissue from Lconj and Lm contained markedly more stem cells than found in Lcor explant tissue; these findings correlate with a higher capacity for growth. Collectively, our findings suggest that explants from the Lconj and Lm sites should be selected for limbal cell expansion for both CLET and SLET procedures. These new insights may guide surgeons toward specific limbal sites that are most suitable for stem cell culture and transplantation and may ultimately improve treatment outcomes in the patients with LSCD.
Asunto(s)
Células Madre Adultas/citología , Limbo de la Córnea/citología , Células Madre Adultas/metabolismo , Células Madre Adultas/trasplante , Secuencia de Aminoácidos , Biomarcadores/metabolismo , Cadáver , Técnicas de Cultivo de Célula , Proliferación Celular , Células Epiteliales/citología , Células Epiteliales/metabolismo , Células Epiteliales/trasplante , Epitelio Corneal/citología , Epitelio Corneal/lesiones , Epitelio Corneal/metabolismo , Humanos , Técnicas In Vitro , Limbo de la Córnea/lesiones , Limbo de la Córnea/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Técnicas de Cultivo de Tejidos , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/metabolismoAsunto(s)
Reprogramación Celular , Cardiopatías/terapia , Células Madre Pluripotentes Inducidas/trasplante , Mioblastos Cardíacos/trasplante , Trasplante de Células Madre/métodos , Células Madre Adultas/citología , Células Madre Adultas/trasplante , Animales , Arritmias Cardíacas/etiología , China , Ensayos Clínicos como Asunto , Modelos Animales de Enfermedad , Cardiopatías/cirugía , Humanos , Células Madre Pluripotentes Inducidas/citología , Japón , Masculino , Persona de Mediana Edad , Mioblastos Cardíacos/citología , Seguridad del Paciente , Proyectos Piloto , Trasplante de Células Madre/efectos adversos , IncertidumbreRESUMEN
Epidermal adult stem cells (EpiASCs) have the potential for unlimited proliferation and differentiation, however, the ability of these stem cells to activate corneal genetic programs in response to corneal stroma stimulation needs to be further validated. Herein, a feasible strategy was developed to reconstruct the damaged corneal surface in a goat model with total limbal stem cell deficiency (LSCD) by transplanting EpiASCs, which had been explanted and cultured from the skin of an adult ram goat and were then purified by selecting single cell-derived clones and cultivating them on a denuded human amniotic membrane (HAM). These artificial tissues were then successfully transplanted into ewe goats with total LSCD. Binding of EpiASCs to the base membrane of an EpiASCs-HAM-Sheet (EHS) indicated their proliferating status. After transplantation, the EpiASCs could survive in the host tissue and they reconstructed the damaged ocular surface of total LSCD. The crystal reconstructed corneal epithelium expressed CK3 and Pax-6 similar to normal corneal epithelium and expressed the Sry gene after transplantation. These results demonstrated that EpiASCs could be induced to differentiate into corneal epithelial cell types in a corneal microenvironment and had the ability to activate corneal genetic programs. This work offer a foundation for promoting tissue-engineered cornea into clinical application.
Asunto(s)
Células Madre Adultas/trasplante , Transdiferenciación Celular/genética , Enfermedades de la Córnea/terapia , Células Epidérmicas/trasplante , Epitelio Corneal/citología , Limbo de la Córnea/citología , Piel/citología , Células Madre Adultas/citología , Amnios/citología , Animales , Células Cultivadas , Células Epidérmicas/citología , Epitelio Corneal/patología , Femenino , Genes sry , Cabras , Humanos , Limbo de la Córnea/patología , Masculino , Trasplante de Células MadreRESUMEN
The trabecular meshwork (TM) is an ocular tissue that maintains intraocular pressure (IOP) within a physiologic range. Glaucoma patients have reduced TM cellularity and, frequently, elevated IOP. To establish a stem cell-based approach to restoring TM function and normalizing IOP, human adipose-derived stem cells (ADSCs) were induced to differentiate to TM cells in vitro. These ADSC-TM cells displayed a TM cell-like genotypic profile, became phagocytic, and responded to dexamethasone stimulation, characteristic of TM cells. After transplantation into naive mouse eyes, ADSCs and ADSC-TM cells integrated into the TM tissue, expressed TM cell markers, and maintained normal IOP, outflow facility, and extracellular matrix. Cell migration and affinity results indicated that the chemokine pair CXCR4/SDF1 may play an important role in ADSC-TM cell homing. Our study demonstrates the possibility of applying autologous or allogeneic ADSCs and ADSC-TM cells as a potential treatment to restore TM structure and function in glaucoma.
Asunto(s)
Células Madre Adultas/citología , Células Madre Adultas/trasplante , Glaucoma/terapia , Malla Trabecular/citología , Tejido Adiposo/citología , Células Madre Adultas/efectos de los fármacos , Animales , Cámara Anterior/citología , Cámara Anterior/inmunología , Apoptosis , Humor Acuoso/fisiología , Diferenciación Celular , Movimiento Celular , Células Cultivadas , Quimiotaxis , Dexametasona/farmacología , Modelos Animales de Enfermedad , Glaucoma/patología , Glaucoma/fisiopatología , Xenoinjertos , Humanos , Técnicas In Vitro , Presión Intraocular/fisiología , Ratones , Fagocitosis , Medicina Regenerativa , Malla Trabecular/fisiologíaRESUMEN
Each year 790,000 people in the United States suffer from a myocardial infarction. This results in the permanent loss of cardiomyocytes and an irreversible loss of cardiac function. Current therapies lower mortality rates, but do not address the core pathology, which opens a pathway to step-wise heart failure. Utilizing stem cells to regenerate the dead tissue is a potential method to reverse these devastating effects. Several clinical trials have already demonstrated the safety of stem cell therapy. In this review, we highlight clinical trials, which have utilized various stem cell lineages, and discuss areas for future research.